SSR180575

SSR180575 · Sanofi

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SSR180575, covering 2017-08-08 to 2017-08-08. Get the full timeline:

Most recent: Clinical Trial Update: Dose-effect of SSR180575 in Diabetic Neuropathy [Phase 2]